OE Headlines: New AAOS Guidelines, Cannabis Guidelines for Pain, Molnupiravir for COVID-19, and more Artwork

OE OrthoPod

Join Dr Mohit Bhandari for uniquely honest, fun and insightful interviews with leading healthcare leaders, innovators and pioneers in orthopaedics. Topic covered include current interests, work/life balance, leadership and clinical areas.

All Episodes

OE OrthoPod

OE Headlines: New AAOS Guidelines, Cannabis Guidelines for Pain, Molnupiravir for COVID-19, and more

October 20, 2021 • OrthoEvidence • Season 3 • Episode 12

OE Headlines:
Medical Cannabis or Cannabinoids for Chronic Pain: A Clinical Practice Guideline https://www.bmj.com/content/374/bmj.n2040

Fast 5 Stories:
1. Emerging Opioid Problem Due to Longer Surgical Wait Lists https://pubmed.ncbi.nlm.nih.gov/34521769/
2. The New AAOS Guidelines-and Injectables https://ryortho.com/breaking/aaos-updates-knee-oa-guideline-highlights-zilretta/
3. Should We Trust Drug Trials That Stop Early for Benefit? https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/
4. Early Weightbearing vs Non Weightbearing After Operative Treatment of an Ankle Fracture https://pubmed.ncbi.nlm.nih.gov/34251882/
5. Degenerative Lumbar Spondylolisthesis: Decompression with or without Fusion https://www.nejm.org/doi/full/10.1056/NEJMoa2100990